Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort

Objectives: On January 18, 2010, a part of the capital region of Denmark shifted the empirical treatment of febrile conditions from cefuroxime to piperacillin/tazobactam. We compare empirical treatment with piperacillin/tazobactam versus cefuroxime for Escherichia coli bacteremia with regard to 14 d...

全面介紹

Na minha lista:
書目詳細資料
發表在:Infect Drug Resist
Main Authors: Thønnings, Sara, Jansåker, Filip, Gradel, Kim Oren, Styrishave, Bjarne, Knudsen, Jenny Dahl
格式: Artigo
語言:Inglês
出版: Dove 2019
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6526191/
https://ncbi.nlm.nih.gov/pubmed/31190913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S197735
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍